These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 18222727)

  • 21. Targeting the myocardial sodium-hydrogen exchange for treatment of heart failure.
    Morris K
    Expert Opin Ther Targets; 2002 Jun; 6(3):291-8. PubMed ID: 12223070
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of Na+/H+ exchanger 1 allosteric balance by its localization in cholesterol- and caveolin-rich membrane microdomains.
    Tekpli X; Huc L; Lacroix J; Rissel M; Poët M; Noël J; Dimanche-Boitrel MT; Counillon L; Lagadic-Gossmann D
    J Cell Physiol; 2008 Jul; 216(1):207-20. PubMed ID: 18264982
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sodium hydrogen exchange 1 (NHE-1) regulates connexin 43 expression in cardiomyocytes via reverse mode sodium calcium exchange and c-Jun NH2-terminal kinase-dependent pathways.
    Stanbouly S; Kirshenbaum LA; Jones DL; Karmazyn M
    J Pharmacol Exp Ther; 2008 Oct; 327(1):105-13. PubMed ID: 18650245
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potential novel pharmacological therapies for myocardial remodelling.
    Landmesser U; Wollert KC; Drexler H
    Cardiovasc Res; 2009 Feb; 81(3):519-27. PubMed ID: 19019834
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Na+/H+ exchanger mediates TNF-alpha-induced hepatocyte apoptosis via the calpain-dependent degradation of Bcl-xL.
    Liu Z; Wang S; Zhou H; Yang Y; Zhang M
    J Gastroenterol Hepatol; 2009 May; 24(5):879-85. PubMed ID: 19220664
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An overview of inhibitors of Na(+)/H(+) exchanger.
    Masereel B; Pochet L; Laeckmann D
    Eur J Med Chem; 2003 Jun; 38(6):547-54. PubMed ID: 12832126
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiovascular effects of NA+/H+ exchanger inhibition with BIIB513 following hypovolemic circulatory shock.
    Wu D; Bassuk J; Arias J; Doods H; Adams JA
    Shock; 2005 Mar; 23(3):269-74. PubMed ID: 15718927
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacologic cardiovascular support.
    Zaloga GP; Prielipp RC; Butterworth JF; Royster RL
    Crit Care Clin; 1993 Apr; 9(2):335-62. PubMed ID: 8490766
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Population pharmacokinetics of eniporide and its metabolite in healthy subjects and patients with acute myocardial infarction.
    Bhattaram VA; Nagaraja NV; Peters T; Machnig T; Kroesser S; Kovar A; Derendorf H
    J Clin Pharmacol; 2005 Jun; 45(6):631-9. PubMed ID: 15901744
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of KR-33028, a novel Na+/H+ exchanger-1 inhibitor, on glutamate-induced neuronal cell death and ischemia-induced cerebral infarct.
    Lee BK; Lee DH; Park S; Park SL; Yoon JS; Lee MG; Lee S; Yi KY; Yoo SE; Lee KH; Kim YS; Lee SH; Baik EJ; Moon CH; Jung YS
    Brain Res; 2009 Jan; 1248():22-30. PubMed ID: 19022230
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Contribution of NHE-1 to cell length shortening of normal and failing rabbit cardiac myocytes.
    van Borren MM; Zegers JG; Baartscheer A; Ravesloot JH
    J Mol Cell Cardiol; 2006 Oct; 41(4):706-15. PubMed ID: 16916522
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional observational battery and motor activity in rats after single administration of two NHE 1 inhibitors.
    Hübler N; Gottschling B; Jacobs M; von Landenberg F; Hewicker-Trautwein M
    Toxicol Appl Pharmacol; 2005 Nov; 208(3):266-76. PubMed ID: 16239169
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Zoniporide: a potent and highly selective inhibitor of human Na(+)/H(+) exchanger-1.
    Marala RB; Brown JA; Kong JX; Tracey WR; Knight DR; Wester RT; Sun D; Kennedy SP; Hamanaka ES; Ruggeri RB; Hill RJ
    Eur J Pharmacol; 2002 Sep; 451(1):37-41. PubMed ID: 12223226
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting histone deacetylases for heart failure.
    Bush EW; McKinsey TA
    Expert Opin Ther Targets; 2009 Jul; 13(7):767-84. PubMed ID: 19466913
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is timing everything? Therapeutic potential of modulators of cardiac Na(+) transporters.
    Doggrell SA; Hancox JC
    Expert Opin Investig Drugs; 2003 Jul; 12(7):1123-42. PubMed ID: 12831348
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The positive inotropic effect of endothelin-1 is mediated by mitochondrial reactive oxygen species.
    De Giusti VC; Correa MV; Villa-Abrille MC; Beltrano C; Yeves AM; de Cingolani GE; Cingolani HE; Aiello EA
    Life Sci; 2008 Aug; 83(7-8):264-71. PubMed ID: 18625248
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Na+/H+ exchanger: an emerging therapeutic target in cardiovascular disorders.
    Sharma A; Singh M
    Drugs Today (Barc); 2000 Nov; 36(11):793-802. PubMed ID: 12845338
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Estrogen exerts concentration-dependent pro-and anti-hypertrophic effects on adult cultured ventricular myocytes. Role of NHE-1 in estrogen-induced hypertrophy.
    Kilić A; Javadov S; Karmazyn M
    J Mol Cell Cardiol; 2009 Mar; 46(3):360-9. PubMed ID: 19111554
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Na+ currents in cardioprotection: better to be late.
    Le Grand B; Pignier C; Létienne R; Colpaert F; Cuisiat F; Rolland F; Mas A; Borras M; Vacher B
    J Med Chem; 2009 Jul; 52(14):4149-60. PubMed ID: 19514733
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular biology of the myocardial Na+/H+ exchanger.
    Fliegel L
    J Mol Cell Cardiol; 2008 Feb; 44(2):228-37. PubMed ID: 18191941
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.